vs

Side-by-side financial comparison of Edible Garden AG Inc (EDBL) and Scilex Holding Co (SCLX). Click either name above to swap in a different company.

Scilex Holding Co is the larger business by last-quarter revenue ($4.8M vs $4.1M, roughly 1.2× Edible Garden AG Inc). On growth, Edible Garden AG Inc posted the faster year-over-year revenue change (6.6% vs -67.8%). Over the past eight quarters, Edible Garden AG Inc's revenue compounded faster (14.8% CAGR vs -33.6%).

Edible Garden AG Inc is a U.S.-based sustainable agricultural company specializing in hydroponically grown fresh organic herbs, leafy greens, and specialty vegetables. It distributes its pesticide-free produce to leading grocery retailers, food service operators, and direct-to-consumer platforms across North America, prioritizing eco-friendly, low-water farming practices.

Scilex Holding Co is a commercial-stage biopharmaceutical firm focused on developing and commercializing innovative non-opioid pain management therapies for acute and chronic pain segments. It primarily serves the US market, offering prescription and over-the-counter pain relief solutions for patients and healthcare providers.

EDBL vs SCLX — Head-to-Head

Bigger by revenue
SCLX
SCLX
1.2× larger
SCLX
$4.8M
$4.1M
EDBL
Growing faster (revenue YoY)
EDBL
EDBL
+74.4% gap
EDBL
6.6%
-67.8%
SCLX
Faster 2-yr revenue CAGR
EDBL
EDBL
Annualised
EDBL
14.8%
-33.6%
SCLX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EDBL
EDBL
SCLX
SCLX
Revenue
$4.1M
$4.8M
Net Profit
$-46.1M
Gross Margin
-29.0%
45.5%
Operating Margin
-138.6%
-2317.8%
Net Margin
-961.9%
Revenue YoY
6.6%
-67.8%
Net Profit YoY
-613.7%
EPS (diluted)
$-109.97
$-4.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EDBL
EDBL
SCLX
SCLX
Q4 25
$4.1M
$4.8M
Q3 25
$2.8M
$10.6M
Q2 25
$3.1M
$9.9M
Q1 25
$2.7M
$5.0M
Q4 24
$3.9M
$14.9M
Q3 24
$2.6M
$14.4M
Q2 24
$4.3M
$16.4M
Q1 24
$3.1M
$10.9M
Net Profit
EDBL
EDBL
SCLX
SCLX
Q4 25
$-46.1M
Q3 25
$-4.0M
$-257.8M
Q2 25
$-4.0M
$-44.0M
Q1 25
$-3.3M
$-26.1M
Q4 24
$-3.1M
$-6.5M
Q3 24
$-2.1M
$-4.4M
Q2 24
$-1.9M
$-37.6M
Q1 24
$-4.0M
$-24.4M
Gross Margin
EDBL
EDBL
SCLX
SCLX
Q4 25
-29.0%
45.5%
Q3 25
9.7%
68.5%
Q2 25
20.2%
66.9%
Q1 25
3.2%
72.3%
Q4 24
0.6%
68.5%
Q3 24
27.1%
73.9%
Q2 24
36.7%
73.2%
Q1 24
0.7%
64.7%
Operating Margin
EDBL
EDBL
SCLX
SCLX
Q4 25
-138.6%
-2317.8%
Q3 25
-126.3%
-1766.2%
Q2 25
-114.2%
-207.2%
Q1 25
-107.7%
-557.5%
Q4 24
-70.8%
-190.5%
Q3 24
-57.7%
-138.0%
Q2 24
-27.7%
-95.4%
Q1 24
-123.3%
-179.0%
Net Margin
EDBL
EDBL
SCLX
SCLX
Q4 25
-961.9%
Q3 25
-143.6%
-2441.5%
Q2 25
-128.5%
-445.1%
Q1 25
-122.3%
-521.2%
Q4 24
-79.5%
-43.4%
Q3 24
-79.8%
-30.4%
Q2 24
-45.3%
-229.6%
Q1 24
-127.0%
-224.0%
EPS (diluted)
EDBL
EDBL
SCLX
SCLX
Q4 25
$-109.97
$-4.63
Q3 25
$1.38
$-22.17
Q2 25
$-6.58
$-7.42
Q1 25
$-2.47
$-2.26
Q4 24
$-330.78
$8.53
Q3 24
$16.32
$-0.58
Q2 24
$-30.02
$-7.67
Q1 24
$-341.14
$-8.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EDBL
EDBL
SCLX
SCLX
Cash + ST InvestmentsLiquidity on hand
$5.0M
Total DebtLower is stronger
$1.7M
Stockholders' EquityBook value
$12.5M
$-207.8M
Total Assets
$20.6M
$365.0M
Debt / EquityLower = less leverage
0.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EDBL
EDBL
SCLX
SCLX
Q4 25
$5.0M
Q3 25
$878.0K
Q2 25
$4.1M
Q1 25
$5.8M
Q4 24
$3.3M
Q3 24
$77.0K
Q2 24
$6.9M
Q1 24
$1.8M
Total Debt
EDBL
EDBL
SCLX
SCLX
Q4 25
$1.7M
Q3 25
$2.7M
Q2 25
$2.0M
Q1 25
$2.4M
Q4 24
$2.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
EDBL
EDBL
SCLX
SCLX
Q4 25
$12.5M
$-207.8M
Q3 25
$12.9M
$-176.9M
Q2 25
$1.6M
$-249.0M
Q1 25
$1.9M
$-211.5M
Q4 24
$4.1M
$-192.6M
Q3 24
$3.3M
$-211.3M
Q2 24
$511.0K
$-214.7M
Q1 24
$-4.1M
$-189.8M
Total Assets
EDBL
EDBL
SCLX
SCLX
Q4 25
$20.6M
$365.0M
Q3 25
$20.1M
$275.9M
Q2 25
$21.8M
$83.8M
Q1 25
$8.5M
$79.0M
Q4 24
$11.9M
$93.0M
Q3 24
$8.9M
$100.4M
Q2 24
$9.9M
$104.5M
Q1 24
$6.3M
$91.2M
Debt / Equity
EDBL
EDBL
SCLX
SCLX
Q4 25
0.13×
Q3 25
0.21×
Q2 25
1.28×
Q1 25
1.24×
Q4 24
0.61×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EDBL
EDBL
SCLX
SCLX
Operating Cash FlowLast quarter
$-2.7M
$-17.5M
Free Cash FlowOCF − Capex
$-2.8M
FCF MarginFCF / Revenue
-66.8%
Capex IntensityCapex / Revenue
2.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-12.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EDBL
EDBL
SCLX
SCLX
Q4 25
$-2.7M
$-17.5M
Q3 25
$-2.4M
$8.2M
Q2 25
$-3.4M
$7.0M
Q1 25
$-3.3M
$6.0M
Q4 24
$-1.8M
$2.5M
Q3 24
$-1.1M
$5.1M
Q2 24
$-4.6M
$2.3M
Q1 24
$-1.1M
$9.4M
Free Cash Flow
EDBL
EDBL
SCLX
SCLX
Q4 25
$-2.8M
Q3 25
$-2.8M
Q2 25
$-3.5M
Q1 25
$-3.4M
Q4 24
$-1.9M
Q3 24
$-1.1M
Q2 24
$-4.7M
Q1 24
$-1.1M
FCF Margin
EDBL
EDBL
SCLX
SCLX
Q4 25
-66.8%
Q3 25
-98.9%
Q2 25
-110.8%
Q1 25
-125.5%
Q4 24
-48.6%
Q3 24
-43.4%
Q2 24
-110.2%
Q1 24
-35.6%
Capex Intensity
EDBL
EDBL
SCLX
SCLX
Q4 25
2.3%
Q3 25
14.5%
Q2 25
1.7%
Q1 25
2.9%
Q4 24
3.3%
Q3 24
0.4%
0.0%
Q2 24
2.6%
Q1 24
1.8%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EDBL
EDBL

Herbs Produce Floral$3.6M86%
Other$576.0K14%

SCLX
SCLX

Segment breakdown not available.

Related Comparisons